Overview
Adam Feldman is a Urologist in Boston, Massachusetts. Dr. Feldman is highly rated in 24 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Cystectomy.
His clinical research consists of co-authoring 102 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
165 Cambridge St Fl 7, Boston, MA 02114
2014 Washington St, Newton Lower Falls, MA 02462
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Massachusetts General Hospital
Brian Eisner is a Urologist in Boston, Massachusetts. Dr. Eisner is highly rated in 24 conditions, according to our data. His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Obstructive Uropathy, Ureteroscopy, and Lithotripsy.
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mark A. Preston is a urologic surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. Dr. Preston received his Medical Degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a Masters of Public Health from the Harvard School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology. Dr. Preston is highly rated in 19 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy.
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is highly rated in 18 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy.
Frequently Asked Questions about Dr. Adam Feldman
How do I make an appointment with Dr. Adam Feldman?
You can book an appointment with Dr. Adam Feldman by calling their office at 857-238-3838. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Adam Feldman a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Adam Feldman is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Adam Feldman specialize in?
While Dr. Adam Feldman is a Urology, they have specific expertise in Renal Cell Carcinoma (RCC), Urothelial Cancer, and Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Adam Feldman participate in research or clinical trials?
Yes. Dr. Adam Feldman has published 102 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Adam Feldman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Adam Feldman accept my insurance?
Dr. Adam Feldman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 857-238-3838 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Feldman isElite. Learn about Bladder Cancer.
- Muscle Invasive Bladder Cancer
- Prostate CancerDr. Feldman isElite. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Feldman isElite. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Feldman isElite. Learn about Urothelial Cancer.
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Feldman isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Feldman isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Feldman isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Feldman isDistinguished. Learn about Familial Wilms Tumor 2.
- NephrectomyDr. Feldman isDistinguished. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder CancerDr. Feldman isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Advanced
- CystectomyDr. Feldman isAdvanced. Learn about Cystectomy.
- EmpyemaDr. Feldman isAdvanced. Learn about Empyema.
- MalakoplakiaDr. Feldman isAdvanced. Learn about Malakoplakia.
- PenectomyDr. Feldman isAdvanced. Learn about Penectomy.
- ProstatectomyDr. Feldman isAdvanced. Learn about Prostatectomy.
- Reconstructive Urology SurgeryDr. Feldman isAdvanced. Learn about Reconstructive Urology Surgery.
- Experienced
- Bilateral HydronephrosisDr. Feldman isExperienced. Learn about Bilateral Hydronephrosis.
- BoilsDr. Feldman isExperienced. Learn about Boils.
- CarbuncleDr. Feldman isExperienced. Learn about Carbuncle.
- EndoscopyDr. Feldman isExperienced. Learn about Endoscopy.
- Enlarged Prostate (BPH)Dr. Feldman isExperienced. Learn about Enlarged Prostate (BPH).
- FolliculitisDr. Feldman isExperienced. Learn about Folliculitis.

